- Online only
Venor® Mycoplasma dPCR enables rapid and reliable detection of mycoplasma in cell cultures, biopharmaceutical products and ATMPs with digital PCR.
- EP 2.6.7 (12.2) and USP <77> compliant
- Highest sensitivity on market through detection of both RNA and DNA
- Compatible with QIAcuity® digital PCR system
- Fast results in < 3 h
Validation Report for Venor® Mycoplasma dPCR
Validation Reports can only be requested by email.
Please contact us via:
support@minerva-biolabs.com
Thank you
Validation Guide for Venor® Mycoplasma dPCR
Please use this form to request a validation guide.
All fields are required. Please use your business contact data.
Please provide your first name. Please provide your last name. The e-mail seems to be missing or incorrect. Please provide your company/institution. Send Validation GuideMycoplasma contamination is a critical risk in cell culture, biopharmaceutical manufacturing, and advanced therapy medicinal products (ATMPs). For product release, EP 2.6.7 and USP <77> require a validated mycoplasma detection method.
Venor® Mycoplasma dPCR is a digital PCR assay for the rapid, sensitive, and reliable detection of mycoplasma contamination in cell cultures, cell culture-derived biologicals, and Advanced Therapy Medicinal Products (ATMPs). The assay has specifically been developed for use with the QIAcuity® digital PCR system and is validated according to EP 2.6.7 (12.2), USP <77>, and in compliance with ICH Q2(R2), meeting criteria for specificity, robustness, and sensitivity with detection limits of ≤ 10 CFU/ml and < 100 GC/ml.
Venor® Mycoplasma dPCR specifically detects mycoplasma by amplifying the highly conserved 16S rRNA coding region of the mycoplasma genome. This enables broad and reliable detection of Mollicutes, including the species listed in the EP and USP. An integrated reverse transcription step allows the assay to detect both mycoplasma DNA and RNA, significantly increasing analytical sensitivity and supporting the detection of low-level contamination.
The kit includes a positive control and an internal control. The external positive control (EPC) / extraction inhibition control (EIC) is not included in the kit. For this purpose, we recommend using 100GC® , 10CFU®, or 100CFU® Mycoplasma Standards.
For product-specific validation (“test for inhibitory substances” or “method suitability test”), we recommend using 100GC® or 10CFU® Mycoplasma Standards.
The kit is provided with comprehensive manufacturer validation data. For sample preparation, we recommend Venor® Mycoplasma Extraction, as it has been validated in combination with Venor® Mycoplasma dPCR.
| Application | Mycoplasma detection |
|---|---|
| Application areas |
|
| Contents |
|
| Compliance | EP 2.6.7, USP <77>, JP18 G3 |
| Validation report | available |
| Time-to-result | < 3 h |
| PCR type | Digital PCR with reverse transcription |
| Compatible devices | QIAcuity® digital PCR device |
| Detection limit (LOD) | ≤ 10 CFU/ml < 100 GC/ml |
| Detection spectrum | ≥ 130 mollicutes |
| Control system |
|
| Number of reactions |
|
| Price per reaction |
|
| Required equipment and consumables |
(Please refer to the manual for complete list and recommendations) |
| Storage | 2-8 °C; ≤ –18 °C after opening or rehydration |
| Shipping | Ambient temperature |
| Shelf life (max.) | 18 months |
For research and industrial use only. Not for diagnostic or therapeutic use.
Minerva Biolabs offers a free sample of this product for testing:
Request free sample